1
Published 2020
Canadian Agency for Drugs and Technologies in Health
... be left in place for three years...

2
Published 2015
Canadian Agency for Drugs and Technologies in Health
... the place in therapy of biological mesh products. Therefore, there is remaining uncertainty regarding...

3
Published 2015
Canadian Agency for Drugs and Technologies in Health
... the place of tramadol in the management of pain in adults. The purpose of this report is to review...

4
Published 2016
Canadian Agency for Drugs and Technologies in Health
... understand its place in therapy relative to existing antimicrobial treatment options. The purpose...

5
Published 2017
Canadian Agency for Drugs and Technologies in Health
... relief, and dental care. Asfotase alfa is a therapeutic protein that acts in place of the defective...

6
Published 2017
Canadian Agency for Drugs and Technologies in Health
... relief, and dental care. Asfotase alfa is a therapeutic protein that acts in place of the defective...

7
Published 2015
Canadian Agency for Drugs and Technologies in Health
... the place in therapy of biological mesh products. Therefore, there is remaining uncertainty regarding...

8
Published 2013
Canadian Agency for Drugs and Technologies in Health
... the dressing is in place and during dressing change may be related to the characteristics of the wound dressing...

9
Published 2015
Canadian Agency for Drugs and Technologies in Health
...; continuity and transition; and access to care. The delivery of this model of care may take place...

10
Published 2013
Canadian Agency for Drugs and Technologies in Health
... the dressing is in place and during dressing change may be related to the characteristics of the wound dressing...

11
Published 2013
Canadian Agency for Drugs and Technologies in Health
.... In the operating room (OR) there are procedures and practices in place intended to reduce the probability...

12
Published 2014
Canadian Agency for Drugs and Technologies in Health
... in thinking and behavior of patients. Therapy sessions can take place weekly with the total number of sessions...

13
Published 2016
Canadian Agency for Drugs and Technologies in Health
... understand its place in therapy relative to existing antimicrobial treatment options. The purpose...

14
Published 2013
Canadian Agency for Drugs and Technologies in Health
.... In the operating room (OR) there are procedures and practices in place intended to reduce the probability...

15
by Tran, Khai, Moulton, Kristen, Santesso, Nancy, Rabb, Danielle
Published 2016
Canadian Agency for Drugs and Technologies in Health
... the choice of behavioural therapy for the treatment of PTSD -- and the place of CPT in therapy -- this study...

16
Published 2013
Canadian Agency for Drugs and Technologies in Health
... of their place in therapy, including the potential for combination therapy. Thus, the comparative clinical...

17
Published 2013
Canadian Agency for Drugs and Technologies in Health
... of their place in therapy, including the potential for combination therapy. Thus, the comparative clinical...

18
Published 2014
Canadian Agency for Drugs and Technologies in Health
...Nephrostomy and biliary tubes are drainage catheters that are placed into the renal collecting...

19
Published 2014
Canadian Agency for Drugs and Technologies in Health
...Nephrostomy and biliary tubes are drainage catheters that are placed into the renal collecting...

20
by Pohar, Ron, Adcock, Lorna
Published 2018
Canadian Agency for Drugs and Technologies in Health
... of assessments for illness in adults, including chest x-rays and other medical assessments, prior to being placed...